Ares Commercial Real Estate Corporation (ACRE)

Score 3 (Mixed): mortgage REIT with meaningful CRE credit risk (office exposure/CECL reserve) and leveraged secured funding; recent quarter improved but YTD results remain weak. Latest 10-K/10-Q did not identify an explicit going-concern warning or disclosed covenant breach. Stock trades around half of reported book value and yields roughly 12%–13% on the current dividend, but that payout depends on credit-loss trajectory.

Dominant signal is a single bearish ongoing_process catalyst: ACRE's construction-loan exposure to Taconic's Iron Horse Labs life-sciences asset, sold at $73M below development cost, with in-window coverage net-negative (announced, partially priced). Sentiment delta is flat (baseline 0.00 vs scoring -0.003), retail mention velocity is indeterminate, and the Red-Flag Screen is clean of severe and moderate flags — but with a known adverse catalyst pending and no constructive offset, the setup is weak rather than mixed.

Weak bearish daily structure: price 4.33 sits below every key average (SMA20 4.54, SMA50 4.56, SMA200 4.88, EMA9 4.40, EMA21 4.49) with MACD negative and under its signal (line -0.08 vs signal -0.05, histogram -0.03), RSI14 35.9 and Williams %R -90. Only the short-term oversold state is constructive, so chart quality is bounce-only (2/5). Independently of the chart, the trade is suppressed by the qualitative override (qualitativeScore 2 < 3), the $5M liquidity floor (~$1.34M actual 20-day average dollar volume), and the in-window material dividend ex-date (2026-09-30, $0.15 = 3.46% of price).